As the obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a ...

The trial will assess Radspherin for the treatment of peritoneal carcinomatosis originating from ovarian cancer. Credit: ...

The trial is funded in part by a $30m grant from the US Biomedical Advanced Research and Development Authority (BARDA).

Pfizer has announced data from the Phase III trial of TALZENNA plus XTANDI in patients with metastatic castration-resistant ...

Clario and PathAI partnered to offer an integrated solution for enhancing efficiency of gastrointestinal (GI) clinical trials ...

The technology is part of a broader industry shift towards precision medicine, says GlobalData analyst Cynthia Stinchcombe.

Viking Therapeutics has announced positive results from its Phase Ib trial of VK0214 in patients with X-linked ...

DiaMedica Therapeutics has received the SAHPRA approval to commence a Phase II trial of DM199 to treat preeclampsia.

Chicago-based Vanqua Bio’s Parkinson’s disease drug has shown proof-of-concept in a first-in-human study, with the company to ...

InnoCare Pharma has announced that its Phase II study of the TYK2 inhibitor ICP-488 for psoriasis treatment met the primary ...

Cassava alleged that the short sellers had launched a “short and distort” campaign which caused a “decline in Cassava ...

Priovant expects topline data from two Phase III trials for its dual TYK2 and Jak1 inhibitor in dermatomyositis and uveitis ...